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Abstract
OBJEVTIVE: To investigate the antioxidant and
hepatoprotective properties of the different ex-
tracts Guizhencao (Herba Bidentis Bipinnatae)
against liver injury in hyperlipidemia rats.
METHODS: The rats were divided into 7 groups,
with 10 rats in each. Rats were treated with high-fat
diet for 18 weeks besides the normal control group,
then rats in both normal control and model groups
were received 5 mL/kg-1·day-1 of saline and those in
the positive control group with 2 mg/kg-1·day-1 of
lovastatin. Rats in the positive control group and
different Guizhencao (Herba Bidentis Bipinnatae) ex-
tracts treatment groups (ethyl acetate extract
group, n-hexane extract group, ethanol extract
group, and aqueous extract group) were treated
with corresponding extract at a concentration of
5 mL/kg-1·day-1. After 8 weeks treatment, all rats
were sacrificed and total blood samples were col-
lected. Histological analysis of liver was underdone
by hematoxylin and eosin. The levels of serum ala-
nine aminotransferase (ALT), aspartate aminotrans-
ferase (AST), glouse (GLU), cholesterol (TC), triglyc-
erides (TG), low-density lipoprotein-cholesterol
(LDL-C) and high-density lipoprotein-cholesterol
were measured according to standard procedure
using auto-analyzer. The superoxide dismutase
(SOD) and malondialdehyde (MDA) levels in liver
were ananlyzed by procedure instruction.
RESULTS: The histopathological analysis implied
that the administration of Guizhencao (Herba Biden-
tis Bipinnatae) extracts resulted in hepatoprotective
role compared with that of the model group. In ad-
dition, the high-fat diet caused a remarkable in-
crease of ALT, AST, GLU, TC, TG, LDL-C and MDA lev-
els. A decline in HDL-C and SOD concentrations
and a reversal of effects were observed in different
Guizhencao (Herba Bidentis Bipinnatae) extracts
groups, especially in the aqueous extract and etha-
nol extract groups.
CONCLUSION: The different extracts of Guizhen-
cao (Herba Bidentis Bipinnatae) can play a protect-
ing role against liver injury in hyperlipidemia rats
maybe through decreasing ALT, AST, GLU, TC, TG,
LDL-C and MDA levels and enhancing the liver an-
ti-oxidative ability.
© 2013 JTCM. All rights reserved.
Key words: Bidens; Antioxidants; Drug-induced liv-
er injury; Hyperlipidemias
lNTRODUCTION
Liver plays an important role in regulating lipid metab-
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olism pathways, including fatty acid b-oxidation, lipo-
genesis, as well as lipoprotein uptake and secretion in
response to nutritional and hormonal signals.1,2 Mean-
while, the liver is also one of the most vulnerable or-
gans and prone to be impaired by lipid over-accumula-
tion.3,4 It has demonstrated that the oxidative stress of
fat metabolism can cause liver disorder, ultimately re-
sults in hyperlipidemia, cardiovascular and chronic liv-
er diseases.1,5,6 Therefore, the great efforts have been in-
vested to exploit the perfect antioxidant drug protect-
ing liver from damage.7,8 Among them, the studies of
Traditional Chinese Medicine have aroused enormous
interest in the world because of its multi-acted-targets
and multi-regulated-approaches in the therapy.9
Guizhencao (Herba Bidentis Bipinnatae), a folk medi-
cine in contemporary China, is highly priced to treat
diabetes, hypertension and arteriosclerosis in duce to
its obvious inhibitory effects on pathogenic microor-
ganisms and strong antioxidant properties.10,11 In some
cases, it is showed that Guizhencao (Herba Bidentis Bi-
pinnatae) has an obvious lipid-lowering role,12,13 but re-
ports on live injury protection in hyperlipidemia are
rear.14 Therefore, this study is performed to investigate
the effects and mechanisms of aqueous extract, ethanol
extract, ethylacetate extract and n-hexane extract of
Guizhencao (Herba Bidentis Bipinnatae) on liver in hy-
perlipidemia rats.
MATERIALS ANDMETHODS
Plant material collection and extraction
Guizhencao (Herba Bidentis Bipinnatae) was collected
in Funiu mountain region of Nanyang in Henan prov-
ince, and was identified and authenticated by Prof.
Zongcai Liu, College of Life Sciences, Nanyang Nor-
mal University. The dried stems and leaves of Guizhen-
cao (Herba Bidentis Bipinnatae) (4.0 kg) were ground
to a fine powder and equally divided into 4 fractions,
followed by successive extraction at room temperature
with distilled water, ethanol, ethyl acetate and n-hex-
ane, respectively. Briefly, filtration and evaporation of
extracts of Guizhencao (Herba Bidentis Bipinnatae)
were performed under reduced pressure at 45℃ , fol-
lowed by lyophilization, and stored at － 20℃ until
use. Finally, the solid form of the extract was dissolved
with dimethyl sulfoxide for use in experiments.
Animals and experiment design
Adult male Sprague-Dawley rats (13-15 weeks, SPF,
SCXKLU20080002) weighing 200-250 g were ob-
tained from Henan Laboratory Animals Center for
Medical Science and Research. The rats were conduct-
ed at a controlled temperature of 19℃-25℃ with a 12∶
12 h light/dark cycle and fed a standard diet. The ex-
periments were conducted according to the National
Institutes of Health Guide for the Care and Use of Lab-
oratory Animals. The rats were treated in accordance
with Committee of Ethicsin Animal Research of Nan-
yang Medical University.
The rats were divided into following 7 groups, with 10
in each. Rats in normal control group were received a
regular rodent chow (normal diet: 62.3% carbohy-
drate, 2.5% fat, 24.3% protein calories). The rest rats
were treated with a high-fat diet (32.6% carbohydrate,
51.0% fat, 16.4% protein calories) for 18 weeks.
When the total cholesterol level in serum of rats feed
high-fat diet attained >3.87 mmol/L, those rats were se-
lected and divided into six subgroups including model
group, positive control group, and four different Gui-
zhencao (Herba Bidentis Bipinnatae) extracts treatment
groups (ethyl acetate extract group, n-hexane extract
group, ethanol extract group, and aqueous extract
group). Subsequently, rats in both normal control and
model groups were received 5 mL/kg-1·day-1 saline and
those in positive control group with 2 mg/kg-1·day-1 of
lovastatin. Rats in different Guizhencao (Herba Biden-
tis Bipinnatae) extracts treatment groups were treated
with 5 mL/kg-1·day-1 corresponding extract, respective-
ly. All these treatments were given orally for 8 weeks,
then the rats were killed by cervical dislocation and
whole blood collected. Serum obtained by immediate
centrifugation of blood samples using centrifuge at
3000 rpm for 15 min. Liver were dissected, immediate-
ly frozen in liquid nitrogen, and then stored at －80℃
until used.
Measurement of growth rate of body weight and
Liver index
The body weight (BW) in each group was recorded on
day 0 (the first day of experiment) and on the last day
(the end time of experiment). The growth rate of body
weight (BW%) was calculated by the following formu-
la.
BW%= {[BW on the last day (g)－BW on day 0 (g)]/
BW on day 0 (g)}×100
The Liver index (LI) of rats was measured by the
Pooja's methods.14
LI=[(wet weight of liver/BW]×100
Histological analysis
A portion of liver tissue was fixed in phosphate-buff-
ered 10% formalin, cut into 5 μm sections and stained
with hematoxylin and eosin (HE). Histological obser-
vations on liver tissues were underdone using light mi-
croscope (Olympus, Kanagawa, Japan).
Determination of biochemical parameters
Serum levels of the alanine aminotransferase (ALT), as-
partate aminotransferase (AST) and glouse (GLU), as
markers of hepatic damage and function, were mea-
sured according to standard procedure using AU2700
Automatic Biochemical Analyzer (Olympus, Kanaga-
wa, Japan). The total cholesterol (TC), triglycerides
(TG), low-density lipoprotein-cholesterol (HDL-C)
and high-density lipoprotein-cholesterol were deter-
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mined according to standard procedure (BOSTER,
Wuhan, China).
Determination of oxidative stress markers
Livers were perfused with chilled normal saline to com-
pletely remove all the blood cells, then cut into small
pieces, placed in 0.2 M phosphate buffer (pH 7.4),
and homogenized using homogenizer to obtain 20%
homogenate. The homogenate was centrifuged at 2500
rpm for 15 min. The lipid peroxidation was deter-
mined by malondialdehyde (MDA) level. In addition,
the uperoxide dismutase (SOD) activity was measured
spectrophotometrically using Superoxide dismutase As-
say Kit (BOSTER, Wuhan, China).
Statistical analysis
The original datas were analyzed by Statistical Package
for Social Sciences software (version 13.0) (SPSS, Inc.,
Chicago, IL, USA). The results were expressed as
mean ± standard error of mean (SEM). The multiple
sets of data comparison were carried out by one-way
analysis of variance (ANOVA) and Brown-forsy way.
The comparison of data between groups were under-
done by least significance difference (LSD) combined
with Tamhane's way. Values with P<0.05 were consid-
ered as statistically significant.
RESULTS
Growth rate of body weight and liver index
The growth rate of body weight and liver index in
model group were significant increased compared with
that in the normal group (Figure 1). In contrast with
the model group, rats treated different extracts of Gui-
zhencao (Herba Bidentis Bipinnatae) resulted in a statis-
tical decline of the growth rate of body weight and liv-
er index (Figure 1).
Histopathologic analysis on liver sections
The liver sections of normal rats showed normal cell
structure with distinct hepatic cells, sinusoidal spaces
and a central vein (Figure 2A). The liver sections of the
model group showed presence of destructive alterations
in the parenchyma, extensive fatty changes, disarrange-
ment of normal hepatic cells with high degree of dam-
age, characterized by the centrilobular necrosis, focal
necrosis, and loss of cell boundary bile duct prolifera-
tion (Figure 2B). The liver sections treated with differ-
ent extracts of Guizhencao (Herba Bidentis Bipinnatae)
and lovastatin exhibited less centrilobular necrosis and
fatty changes compared with that in the model group.
Meanwhile, the administration of Guizhencao (Herba
Bidentis Bipinnatae) aqueous extract showed perfect
hepatoprotective activity in rats, then the ethanol ex-
tract and ethyl acetate extract (Figure 2C-2E).
Biochemical parameters
The concentrations of ALT, AST and GLU in the model
group increased significantly in contrasted with those
in the normal group. After treatment of Guizhencao
(Herba Bidentis Bipinnatae) ethanol extract, the levels
of ALT and AST decreased by 34.9% (P<0.05) and
52.8% (P<0.01), respectively, while in the aqueous ex-
tract group by 34.1% (P<0.05) and 46.6% (P<0.05) as
compared with those in the model group. Among the
7 groups, the lowest level of GLU was detected in the
ethylacetate extract group in which it reduced by
61.1% (P<0.01) as compared with that in the model
group and 35.0% (P<0.05) in the positive control
group (Table 1).
Compared with that in the model group, the levels of
TC, TG and LDL-C in other groups were obviously
decreased. After treatment with ethyl acetate extract,
the contents of TC and LDL-C respectively decreased
by 35.8% (P<0.05) and 45.3% (P<0.01), and HDL-C
increased by 73.7% (P<0.01). The levels of TC and
LDL-C in aqueous extract group was reduced by
29.5% (P<0.05) and 45.1% (P<0.01), respectively, but
the HDL-C increased by 77.6% (P<0.01) (Table 1).
a
b b
cc c
A
b
Figure 1 Effects of different extracts of Guizhencao (Herba Bi-
dentis Bipinnatae) on growth rate of body weight and liver
index
A and B were the results of the growth rate of body weight
and liver index, respectively. Bars were normal control
group (Ⅰ), model group (Ⅱ), positive control group (Ⅲ),
ethylacetate extracts group (Ⅳ), n-hexane extract group
(Ⅴ), aqueous extract group (Ⅵ) and ethanol extract group
(Ⅶ). n=9. aP<0.01 vs normal control group. bP<0.05, cP<0.01
vsmodel group.
B
a
c c
ccc
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Oxidative stress
In the ethys acetate extract, aqueous extract, and etha-
nol extract groups, SOD expression level increased by
more than 21.7% (P<0.05) and the MDA level re-
duced by less than 18.8% (P<0.05) compared with
that in the model group (Table 2).
DISCUSSION
Hyperlipidemia is considered to be one of the major
risk factors for liver diseases, such as cirrhosis, hepato-
cellular carcinoma and liver failure.1,15,16 In the Chinese
medicine, many plants are used as hypolipidemic drugs
and played an important protecting role in liver dis-
ease.3,17,18 Among them, Guizhencao (Herba Bidentis Bi-
pinnatae) is attracting great interest in the oriental tra-
ditional medicine.12,13
Present results showed that oral administration of dif-
ferent Guizhencao (Herba Bidentis Bipinnatae) extracts
resulted in decline of the growth rate of body weight
and liver index, reduction of serum TC, TG and
LDL-C levels, and evaluation of HDL-C content, indi-
cating the different extracts contributed to reduce the
lipid accumulation in hyperlipidemia rats. It has been
well established that high-fat diet plays an important
role in the etiology of hyperlipidemia and atherosclero-
sis.19,20 The continuous administration of high-fat diet
can lead to the elevation in major parameters of lipid
profile including TC, TG and LDL-C, and reduction
of HDL-C.
The histological analysis imply that Guizhencao (Her-
ba Bidentis Bipinnatae) extracts treatment may reduce
hepatocellular damage, especially in ethanol extract
and aqueous extract groups, reflecting the different ex-
tracts may play an protecting role in liver damage
caused by high-fat diet. It is further indicated that the
ways and/or targets acted by different extracts in the
protection are not similar. The high level of serum ALT
and AST is interpreted as a result of hepatocellular
damage.21-23 In the present study, the different extracts
treatment resulted in a notable decrease of ALT and
AST levels as compared with those in the model group,
and the significant decline mainly occurred in the etha-
nol extract and aqueous extract groups. The results are
Notes: rats in normal control group and model group were treated with 5 mL/kg-1·day-1 of saline. Rats in positive control group were re-
ceived 2 mg/kg-1·day-1 of lovastatin. Rats in ethylacetate extract group, n-hexane extract group, ethanol extract group and aqueous extract
group were treated with corresponding extract of Guizhencao (Herba Bidentis Bipinnatae) at a concentration of 5 mL/kg-1·day-1. ALT: ala-
nine aminotransferase; AST: aspartate aminotransferase; GLU: glouse; TC: cholesterol; TG: triglycerides; LDL-C: low-density lipopro-
tein-cholesterol; HDL-C: high-density lipoprotein-cholesterol. aP<0.01, dP<0.05 vs normal control group; bP<0.01, cP<0.05 vs model
group; eP<0.05, fP<0.01 vs positive control group.
Group
Normal
control
Model
Positive
control
Ethylacetate
extract
N-hexane
extract
Ethanol
extract
Aqueous
extract
n
9
9
9
9
9
9
9
ALT
(U/L)
30.025±3.525
57.130±9.332a
30.088±4.504b
52.876±5.150
48.924±8.106c
36.496±5.474c
37.651±7.332c
AST
(U/L)
104.364±7.627
197.521±34.051a
110.665±8.202c
136.813±5.788
124.681±29.591
93.064±9.323b
105.418±10.795b
GLU
(mmol/L)
2.225±0.158
3.992±0.624d
3.009±0.533
1.956±0.705be
2.628±0.326
2.606±0.354
3.737±0.437
TC
(mmol/L)
2.818±0.189
4.411±1.114a
3.006±0.511b
3.022±0.578c
3.913±0.447
3.775±0.821
3.143±0.192c
TG
(mmol/L)
0.373±0.073
0.780±0.155a
0.501±0.041c
0.547±0.027
0.515±0.036
0.445±0.069c
0.598±0.055
LDL-C
(mmol/L)
0.835±0.093
2.279±0.124a
1.013±0.119b
1.241±0.135bf
2.242±0.192
2.243±0.177
1.218±0.376bf
HDL-C
(mmol/L)
1.952±0.115
1.037±0.405d
1.093±0.221
1.794±0.323be
1.534±0.216
1.255±0.127
1.839±0.264be
Table 1 Effects of different extracts of Guizhencao (Herba Bidentis Bipinnatae) on biochemical parameters ( xˉ ±s)
GE F
DCBA
Figure 2 Histopathological changes occurred in liver (hematoxylin and eosin ×200)
A: normal control group; B: model group; C: positive control group; D: ethylacetate extract group; E: n-hexane extract group; F:
ethanol extract group; G: aqueous extract group.
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responding to the obvious protecting role of ethanol ex-
tract and aqueous extract in liver cells.
Further research showed a remarkable induction of
SOD expression and decrease of MDA levels were de-
tected in aqueous extract and ethanol extract, suggest-
ing the protecting role on liver of hyperlipidemia rat
model is associated with enhancing antioxidant ability
of rats. It was well known that MDA is considered as a
biomarker to assay the lipid peroxidation which is
prone to cause damage and failure of antioxidant de-
fense capacity,24 that bring about the formation of ex-
cessive toxic species which in turn accelerate the cell
damage.25,26 Similar studies on other Chinese herbs
have been reported.27,28 The SOD possesses stronger
scavenging properties to decompose these toxic spe-
cies.4,6 Therefore, the lower MDA concentration and
higher SOD level are attributed to preventing hepato-
cellular damage. It is worth noting that ethylacetate ex-
tract treatment resulted in drop of GLU and MDA
concentration and increase of SOD level, showing the
different approaches were involved in the antioxidant
event among different Guizhencao (Herba Bidentis Bi-
pinnatae) extracts. It is also supposed that the complex
components may be existed in ethylacetate extract of
Guizhencao (Herba Bidentis Bipinnatae) which plays a
potential role in lowering GLU level. Those works
need to be further explored in the future.
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